ReviewJournal of child neurology2012

Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia.

Elisabetta Soragni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.